ADIPOQ and chronic kidney disease: It has been proposed that high circulating adiponectin levels in various populations such as heart failure, ischemic heart disease or CKD etc. might be attributed to counter-regulatory upregulation of adiponectin production in response to various stresses caused by such severe chronic diseases2,13–15,17,21.